tm logo
ACEPODIA
Live/Pending
NOTICE OF ALLOWANCE - ISSUED

issued

on 11 Jun 2024

Last Applicant/ Owned by

Xintai 5th Rd., Xizhi Dist.

New Taipei City

TW

22175

Serial Number

98044259 filed on 15th Jun 2023

Registration Number

N/A

Correspondent Address

Evan R. Witt

Evan R. Witt KIRTON MCCONKIE

SALT LAKE CITY, UT 84111

United States

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

ACEPODIA

Biological preparations for use in cell cultures for medical or therapeutic purposes; Biological tissue cultures for medical purposes; Medicinal preparations for the treatment and prevention of cancer, tumors, autoimmune disease, neuronal disease, hematopoietic cell-related disease, metabolic syndrome, infectious diseases, immune disease, inflammation and inflammatory diseases for human purposes; Read More

Classification Information


Class [005]
Pharmaceutical Products


Biological preparations for use in cell cultures for medical or therapeutic purposes; Biological tissue cultures for medical purposes; Medicinal preparations for the treatment and prevention of cancer, tumors, autoimmune disease, neuronal disease, hematopoietic cell-related disease, metabolic syndrome, infectious diseases, immune disease, inflammation and inflammatory diseases for human purposes; Drugs, namely, pharmaceuticals for the treatment and prevention of cancer, tumors, autoimmune disease, neuronal disease, hematopoietic cell-related disease, metabolic syndrome, infectious diseases, immune disease, inflammation and inflammatory diseases for medical purposes; Pharmaceutical preparations for the treatment and prevention of cancer, tumors, autoimmune disease, neuronal disease, hematopoietic cell-related disease, metabolic syndrome, infectious diseases, immune disease, inflammation and inflammatory diseases; Cells for clinical, medical, veterinary, or therapeutic purposes or use; Cell-derived preparations, namely, natural killer cell, gamma delta T cell, or other immune cell-derived preparations, for clinical, medical, veterinary, or therapeutic purposes; Therapeutic products derived from cells or cell-derived preparations, namely, natural killer cells, gamma delta T cell, and other immune cell, for clinical, medical, veterinary, or therapeutic purposes; Kits comprised of cells and reagents and also containing related instructions for clinical, medicinal, veterinary, or therapeutic purposes or use; Kits comprised of cell-derived preparations, namely, natural killer cell, gamma delta T cell, and other immune cell-derived preparations and reagents and also containing related instructions, for clinical, medicinal, veterinary, or therapeutic purposes or use; Gene therapy products, namely, genetically engineered cells for medical or clinical purposes or use; Pharmaceutical preparations, pharmaceutical products, therapeutic agents, and pharmaceuticals for targeting tissues based on select tissue markers and ligands, or for the purpose of binding ligands using engineered proteins and receptors; Pharmaceuticals, namely, pharmaceutical preparations, pharmaceutical products, therapeutic agents, and pharmaceuticals for use in the prevention and treatment of cancer, tumors, hematologic disease, solid cancers, hyperproliferative disease, autoimmune disease, neuronal diseases, hematopoietic cell-related diseases, metabolic syndrome, infectious diseases, immune disease or disorder, and inflammation and inflammatory diseases and in cellular transplants; Biotechnology and pharmaceutical products, namely, therapeutic cells, therapeutic peptide, therapeutic proteins, and therapeutic nucleic acids for human use for the treatment and prevention of cancer, tumors, autoimmune disease, a neuronal disease, a hematopoietic cell-related disease, metabolic syndrome, infectious diseases, immune disease, inflammation and inflammatory diseases; Pharmaceutical preparations or pharmaceutical products, namely, cell media for use in activating t-cells for use in adoptive t-cell therapy for the treatment of hematological and solid cancers; Pharmaceutical preparations, biological preparations, and therapeutic agents to modulate cell function or cell fate; Reagents for medical research, pharmaceutical drug discovery and development, pre-clinical, clinical, and medical use; Biological preparations and therapeutic agents used for medical cell therapy, adoptive immunotherapy, or other immunotherapy; Therapeutic cell preparation based on NK cells (natural killer cells), gamma delta T cell, other immune cell, or other cell for the treatment of cancer, tumors, neuronal diseases, hematopoietic cell-related diseases, metabolic syndrome, infectious diseases, auto-immune diseases, and inflammatory and immune disorders; Bio-engineered component for a therapeutic material, namely, cell lines based on NK cells (natural killer cells), gamma delta T cell, or other immune cell used for medical or clinical use used for immunotherapy


First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details


Serial Number

No 98044259

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 35596.3

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
26th Nov 2024SOU TEAS EXTENSION RECEIVED
11th Jun 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
16th Apr 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
16th Apr 2024PUBLISHED FOR OPPOSITION
27th Mar 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08th Mar 2024APPROVED FOR PUB - PRINCIPAL REGISTER
08th Mar 2024NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
08th Mar 2024EXAMINERS AMENDMENT E-MAILED
08th Mar 2024EXAMINERS AMENDMENT -WRITTEN
08th Mar 2024EXAMINER'S AMENDMENT ENTERED